NRX Pharmaceuticals, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NRX Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $47.32M.
- NRX Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $7.50M.
- NRX Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $3.09M.
- NRX Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $10.00K, a 99.94% decline from fiscal 2021.
- NRX Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $16.70M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $3.09M 10-K · filed 2026-03-23 | |
| 2022-12-31 | $10.00K 10-K · filed 2023-03-31 | |
| 2021-12-31 | $16.70M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $47.32M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $7.50M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |